KYMR
Kymera Therapeutics, Inc. · Healthcare
Director Bruce Booth sold $12.0M of Kymera Therapeutics, Inc.
Sold$11,985,954
$31.36Price
382,244Shares
−29%Stake
What KYMR did after the filing
- The stock from Mon, Dec 19 open, $28.48
- +36.1%
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Feb 2 close.
Traded Wed, Dec 14. Filed Fri, Dec 16, 5:05 PM ET, after the close. Returns use the Dec 19 open and the Feb 2 close. Not investment advice.